GR-1405

• Target :

  PD-1/PD-L1

• Related Pathways :

  Immunology/Inflammation|||Cell Cycle/Checkpoint|||Apoptosis

• Bioactivity :

  GR-1405 is a human monoclonal antibody (mAb) that targets B7-H1/PD-L1/CD274. It enhances the antitumor immune response mediated by cytotoxic T lymphocytes (CTL) against tumor cells expressing PD-L1. GR-1405 is applicable in research related to lymphomas and solid tumors.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C